CataloniaBio & HealthTech will hold its General Assembly on 14 February at the Oriol Bohigas Conference Room (Ateneu Barcelonès). Prior to our ordinary General Assembly, CataloniaBio & HealthTech will hold a Taxation Forum to discuss the impact that tax measures have on investors, entrepreneurs, researchers and R&D generated in the sector.

Among the aspects that generate concern and interest among our community are the improvement of taxation in the field of entrepreneurship. For all the agents involved, both for entrepreneurs and private equity funds, in the returns obtained and stock options. Also, the revision of the wealth tax on assets from entrepreneurial economic activity, which generates a double taxation of the profit and conservation of entrepreneurs' assets, thus limiting the growth of the emerging business fabric. Finally, it applies measures, such as tax credits, which work very well in other countries to encourage spending on research, innovation and technology (partially reimbursed afterwards).

The Tax Forum will be included in the events of the Health Innovation Week.

IMPORTANT!
This event consists of a public session and an exclusive session for CataloniaBio & HealthTech members. Please indicate when registering which sessions you plan to attend.

Programme

9.00h.       Accreditations

9.30h.       Institutional welcome

9.45h.      Taxation forum

• Key insights: "Personal income taxation of value-linked remuneration schemes for founders and employees and implications for the taxation of their assets"
  • Mónica Sevilla González, partner Garrigues
  • Nuria Cabré Plana, partner Garrigues
• Round table: "Tax incentives in the health sector: opportunities and challenges"
  • Jordi Rovira, CFO Vytrus Biotech (moderator)
  • David Alonso, CFO Hipra
  • Esther Riambau, CEO and cofounder Oniria Therapeutics
  • Lluís Juncà, Director General for Innovation, Digital Economy ans Entrepreneurship, Generalitat de Catalunya

11.00h.      Coffee break

11.30h.      CataloniaBio & HealthTech Ordinary General Assembly

This part of the day is exclusively for CataloniaBio & HealthTech members

During the session, the 2023 management report will be presented, the 2024 action plan and budget will be explained, together with the new Strategic Plan; and the new members will give a brief speech as a welcome to the association.

CataloniaBio& HealthTech is currently made up of more than 220 companies and knowledge agents who are leaders in research, development and innovation (R+D+I) in the life and health sciences sector in Catalonia.

Attendance to this part of the meeting must be confirmed.

Language: Catalan

Registration: free (attendance at the Assembly is exclusively for members of CataloniaBio & HealthTech)

Questions: paula.serra@cataloniabioht.org